Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KYMR - Kymera Therapeutics, Inc.
55 M
LAST VALUE
23.06%
2 YEAR CAGR
70.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR